NP-G2-044 Uses, Dosage, Side Effects and more
NP-G2-044 is under investigation in clinical trial NCT03199586 (Phase 1 Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Solid Tumors (Including Lymphoma)).
| Trade Name | NP-G2-044 |
| Generic | NP-G2-044 |
| Type | |
| Formula | C21H16F3N3O2 |
| Weight | Average: 399.373 Monoisotopic: 399.119461256 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
